Breast Cancer Gene Investigators Prepare For The Next Showdown

The researchers who found BRCA1, and the 'also-rans,' have many remaining avenues for ground-breaking studies When the public was informed that a team of scientists led by University of Utah geneticist Mark Skolnick had found a breast cancer susceptibility gene, it indeed appeared to be what Science called in a news report "a fitting finale to one of the most riveting of the fierce and grueling gene hunts that have come to epitomize life in the fast lane of genetics research" (R. Nowak, 265:1

Written bySteven Benowitz
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


The researchers who found BRCA1, and the 'also-rans,' have many remaining avenues for ground-breaking studies
When the public was informed that a team of scientists led by University of Utah geneticist Mark Skolnick had found a breast cancer susceptibility gene, it indeed appeared to be what Science called in a news report "a fitting finale to one of the most riveting of the fierce and grueling gene hunts that have come to epitomize life in the fast lane of genetics research" (R. Nowak, 265:1796-9, 1994).

The theatrical aspect of the long-anticipated discovery was highlighted by the fact that the story was broken by NBC News nearly a month before the papers were published. Following that September 13 television report, Science decided to print its news story in its September 23 edition, although the articles themselves did not appear in the journal until October 7.

By now, the champagne corks have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies